Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial.
Hematology (Amsterdam, Netherlands)
View this publicationHematology (Amsterdam, Netherlands)
View this publicationRheumatology (Oxford, England)
View this publicationLung cancer (Amsterdam, Netherlands)
View this publicationFrontiers in immunology
View this publicationJournal of hepatocellular carcinoma
View this publicationLeukemia
View this publicationFrontiers in immunology
View this publicationHematology (Amsterdam, Netherlands)
View this publicationInfection
View this publicationEuropean urology oncology
View this publication